BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6531213)

  • 1. Determination of myocardial FFA elimination rates by functional images of uncorrected half-time values.
    Visser FC; Van Lingen A; Westera G; Eenige van MJ; Den Hollander W; Van der Wall EE; Heidendal GA; Roos JP
    Nuklearmedizin; 1984 Dec; 23(6):277-82. PubMed ID: 6531213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial scintigraphy with 123I-labelled heptadecanoic acid in patients with unstable angina pectoris.
    van der Wall EE; Heidendal GA; den Hollander W; Westera G; Roos JP
    Postgrad Med J; 1983; 59 Suppl 3():38-40. PubMed ID: 6647209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial imaging and metabolic studies with [17-123I]iodoheptadecanoic acid.
    Freundlieb C; Höck A; Vyska K; Feinendegen LE; Machulla HJ; Stöcklin G
    J Nucl Med; 1980 Nov; 21(11):1043-50. PubMed ID: 7431103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction.
    van der Wall EE; den Hollander W; Heidendal GA; Westera G; Majid PA; Roos JP
    Eur J Nucl Med; 1981; 6(9):383-9. PubMed ID: 7274288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardial scintigraphy with iodine 123-labeled fatty acids].
    Dudczak R
    Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized noninvasive assessment of myocardial free fatty acid kinetics by means of 15-(p-iodo-phenyl) pentadecanoic acid (123I-pPPA) scintigraphy: II. Clinical results.
    Wieler H; Kaiser KP; Kuikka JT; Henkel B; Frank J; Ladwein K
    Nucl Med Commun; 1992 Mar; 13(3):168-85. PubMed ID: 1557216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nuclear medicine functional diagnosis of the myocardium using (123) I-heptadecanoic acid].
    Mende T; Lohr E; Hliscs R; Franke WG; Dauterstedt R
    Z Gesamte Inn Med; 1988 Apr; 43(8):202-5. PubMed ID: 3261066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial imaging with radiolabelled free fatty acids: a critical review.
    van der Wall EE
    Eur Heart J; 1985 Aug; 6 Suppl B():29-38. PubMed ID: 3910439
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of cardiac metabolism with 123I-labelled fatty acids and 11C-methylglucose (author's transl)].
    Vyska K; Höck A; Freundlieb C; Becker V; Schmid A; Kloster G; Kloster G; Stöcklin G
    Nuklearmedizin; 1981 Jun; 20(3):148-55. PubMed ID: 6973145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of gallopamil on iodine-123-phenyl-pentadecanoic acid and thallium 201 uptake in patients with coronary heart disease].
    Tillmanns H; Zimmermann R; Kapp M; Rauch B; Neumann FJ; Schlumpp K; Bubeck B; Georgi P; Kübler W
    Z Kardiol; 1989; 78 Suppl 5():77-82. PubMed ID: 2698567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tomoscintigraphic assessment of myocardial metabolic heterogenity.
    Roesler H; Hess T; Weiss M; Noelpp U; Mueller G; Hoeflin F; Kinser J
    J Nucl Med; 1983 Apr; 24(4):285-96. PubMed ID: 6834135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitation of coronary artery lesions by 2-4 hour stress-myocardial clearance of thallium-201].
    Higuma N; Sato H; Oda H; Oda Y; Yamazoe M
    J Cardiogr; 1986 Dec; 16(4):861-72. PubMed ID: 3429904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [201-thallium stress scintigram in patients with coronary artery disease after administration of the cardioselective betablocker atenolol (author's transl)].
    Chlup J; Engel HJ; Pretschner P; Lichtlen PR
    Z Kardiol; 1981 Jun; 70(6):450-4. PubMed ID: 7257500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris.
    van der Wall EE; Heidendal GA; den Hollander W; Westera G; Roos JP
    Eur J Nucl Med; 1981; 6(9):391-6. PubMed ID: 7274289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of studies with radioiodinated heptadecanoic acid in patients with coronary artery disease.
    van Eenige MJ; Visser FC; Duwel CM; Roos JP
    Eur Heart J; 1990 Mar; 11(3):258-68. PubMed ID: 2180712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart].
    Kaiser KP; Feinendegen LE
    Herz; 1987 Feb; 12(1):41-50. PubMed ID: 3493962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 201thallium imaging clinically valuable in coronary artery disease?
    McKillop JH
    Crit Rev Diagn Imaging; 1982; 18(3):167-96. PubMed ID: 6751696
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of myocardial 42 K uptake with coronary arteriography.
    Bennett KR; Smith RO; Lehan PH; Hellems HK
    Radiology; 1972 Jan; 102(1):117-24. PubMed ID: 5008131
    [No Abstract]   [Full Text] [Related]  

  • 19. The myocardial elimination rate of radioiodinated heptadecanoic acid.
    Visser FC; Westera G; van Eenige MJ; Van der Wall EE; Den Hollander W; Roos JP
    Eur J Nucl Med; 1985; 10(3-4):118-22. PubMed ID: 3996438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of myocardial time-activity curves of 123I-heptadecanoic acid. I. Curve fitting.
    Van Eenige MJ; Visser FC; Duwel CM; Bezemer PD; Westera G; Karreman AJ; Roos JP
    Nuklearmedizin; 1987 Dec; 26(6):241-7. PubMed ID: 3438167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.